Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Gaffo

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Seminars in Arthritis and Rheumatism|June 20, 2020
The experience of a gout flare: a meta-synthesis of qualitative studiesSarah Stewart, Andrea Garcia Guillen, William J Taylor, et al.
The Lancet. Rheumatology|February 7, 2022
Gout and the risk of COVID-19 diagnosis and death in the UK Biobank: a population-based studyRuth K Topless, Angelo Gaffo, Lisa K Stamp, et al.
Arthritis Care & Research|January 3, 2025
Relationship Between Gout Flare States and Patient-Reported Outcomes After Allopurinol InitiationLisa K Stamp, Chris Frampton, Sarah Stewart, et al.
The American Journal of Managed Care|September 15, 2005
A group randomized trial to improve safe use of nonsteroidal anti-inflammatory drugsJeffrey R Curtis, Jason Olivieri, Jeroan J Allison, et al.
The Journal of Rheumatology|November 2, 2021
Which Attributes Are Most and Least Important to Patients When Considering Gout Flare Burden Over Time? A Best-worst Scaling Choice StudyJeremy Holyer, William J Taylor, Angelo Gaffo, et al.
Annals of the Rheumatic Diseases|September 2, 2016
Renal dosing of allopurinol results in suboptimal gout careTuhina Neogi, Nicola Dalbeth, Lisa Stamp, et al.
Nature Reviews. Rheumatology|March 13, 2024
The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with goutChio Yokose, Natalie McCormick, Abhishek Abhishek, et al.
Arthritis Care & Research|May 11, 2019
Coexistent Hyperuricemia and Gout in Rheumatoid Arthritis: Associations With Comorbidities, Disease Activity, and MortalityAndrew Chiou, Bryant R England, Harlan Sayles, et al.
Hypertension (Dallas, Tex. : 1979)|February 15, 2022
Racial Differences in XO (Xanthine Oxidase) and Mitochondrial DNA Damage-Associated Molecular Patterns in Resistant HypertensionBrittany Butts, Jamelle A Brown, Thomas S Denney, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 26, 2025
Comparative Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drug Versus Colchicine Use When Initiating Urate-Lowering Therapy Among Patients With Gout: Target Trial EmulationsChio Yokose, Natalie McCormick, Na Lu, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Seminars in Arthritis and Rheumatism|June 20, 2020
The experience of a gout flare: a meta-synthesis of qualitative studiesSarah Stewart, Andrea Garcia Guillen, William J Taylor, et al.
The Lancet. Rheumatology|February 7, 2022
Gout and the risk of COVID-19 diagnosis and death in the UK Biobank: a population-based studyRuth K Topless, Angelo Gaffo, Lisa K Stamp, et al.
Arthritis Care & Research|January 3, 2025
Relationship Between Gout Flare States and Patient-Reported Outcomes After Allopurinol InitiationLisa K Stamp, Chris Frampton, Sarah Stewart, et al.
The American Journal of Managed Care|September 15, 2005
A group randomized trial to improve safe use of nonsteroidal anti-inflammatory drugsJeffrey R Curtis, Jason Olivieri, Jeroan J Allison, et al.
The Journal of Rheumatology|November 2, 2021
Which Attributes Are Most and Least Important to Patients When Considering Gout Flare Burden Over Time? A Best-worst Scaling Choice StudyJeremy Holyer, William J Taylor, Angelo Gaffo, et al.
Annals of the Rheumatic Diseases|September 2, 2016
Renal dosing of allopurinol results in suboptimal gout careTuhina Neogi, Nicola Dalbeth, Lisa Stamp, et al.
Nature Reviews. Rheumatology|March 13, 2024
The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with goutChio Yokose, Natalie McCormick, Abhishek Abhishek, et al.
Arthritis Care & Research|May 11, 2019
Coexistent Hyperuricemia and Gout in Rheumatoid Arthritis: Associations With Comorbidities, Disease Activity, and MortalityAndrew Chiou, Bryant R England, Harlan Sayles, et al.
Hypertension (Dallas, Tex. : 1979)|February 15, 2022
Racial Differences in XO (Xanthine Oxidase) and Mitochondrial DNA Damage-Associated Molecular Patterns in Resistant HypertensionBrittany Butts, Jamelle A Brown, Thomas S Denney, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 26, 2025
Comparative Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drug Versus Colchicine Use When Initiating Urate-Lowering Therapy Among Patients With Gout: Target Trial EmulationsChio Yokose, Natalie McCormick, Na Lu, et al.
Pageof 4